4clm: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:


==Structure of Salmonella typhi type I dehydroquinase irreversibly inhibited with a 1,3,4-trihydroxyciclohexane-1-carboxylic acid derivative==
==Structure of Salmonella typhi type I dehydroquinase irreversibly inhibited with a 1,3,4-trihydroxyciclohexane-1-carboxylic acid derivative==
<StructureSection load='4clm' size='340' side='right' caption='[[4clm]], [[Resolution|resolution]] 1.40&Aring;' scene=''>
<StructureSection load='4clm' size='340' side='right'caption='[[4clm]], [[Resolution|resolution]] 1.40&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[4clm]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/"bacillus_typhi"_schroeter_1886 "bacillus typhi" schroeter 1886]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CLM OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4CLM FirstGlance]. <br>
<table><tr><td colspan='2'>[[4clm]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Salmonella_enterica_subsp._enterica_serovar_Typhi Salmonella enterica subsp. enterica serovar Typhi]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CLM OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4CLM FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=LI:LITHIUM+ION'>LI</scene>, <scene name='pdbligand=WPL:(1S,3R,4R,5R)-3-(AMINOMETHYL)-1,4,5-TRIHYDROXYCYCLOHEXANECARBOXYLIC+ACID'>WPL</scene></td></tr>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.4&#8491;</td></tr>
<tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[4ckw|4ckw]], [[4ckx|4ckx]], [[4cky|4cky]], [[4ckz|4ckz]], [[4cl0|4cl0]]</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CL:CHLORIDE+ION'>CL</scene>, <scene name='pdbligand=LI:LITHIUM+ION'>LI</scene>, <scene name='pdbligand=WPL:(1S,3R,4R,5R)-3-(AMINOMETHYL)-1,4,5-TRIHYDROXYCYCLOHEXANECARBOXYLIC+ACID'>WPL</scene></td></tr>
<tr id='activity'><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/3-dehydroquinate_dehydratase 3-dehydroquinate dehydratase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=4.2.1.10 4.2.1.10] </span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4clm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4clm OCA], [https://pdbe.org/4clm PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4clm RCSB], [https://www.ebi.ac.uk/pdbsum/4clm PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4clm ProSAT]</span></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4clm FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4clm OCA], [http://pdbe.org/4clm PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4clm RCSB], [http://www.ebi.ac.uk/pdbsum/4clm PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4clm ProSAT]</span></td></tr>
</table>
</table>
== Function ==
[https://www.uniprot.org/uniprot/AROD_SALTI AROD_SALTI]
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 20: Line 21:


==See Also==
==See Also==
*[[Dehydroquinase|Dehydroquinase]]
*[[Dehydroquinase 3D structures|Dehydroquinase 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
[[Category: Bacillus typhi schroeter 1886]]
[[Category: Large Structures]]
[[Category: 3-dehydroquinate dehydratase]]
[[Category: Salmonella enterica subsp. enterica serovar Typhi]]
[[Category: Blanco, B]]
[[Category: Blanco B]]
[[Category: Gonzalez-Bello, C]]
[[Category: Gonzalez-Bello C]]
[[Category: Hawkins, A R]]
[[Category: Hawkins AR]]
[[Category: Lamb, H]]
[[Category: Lamb H]]
[[Category: Lence, E]]
[[Category: Lence E]]
[[Category: Llamas-Saiz, A L]]
[[Category: Llamas-Saiz AL]]
[[Category: Maneiro, M]]
[[Category: Maneiro M]]
[[Category: Otero, J M]]
[[Category: Otero JM]]
[[Category: Peon, A]]
[[Category: Peon A]]
[[Category: Poza, S]]
[[Category: Poza S]]
[[Category: Raaij, M J.van]]
[[Category: Sedes A]]
[[Category: Sedes, A]]
[[Category: Tizon L]]
[[Category: Tizon, L]]
[[Category: Van Raaij MJ]]
[[Category: Inhibitor]]
[[Category: Lyase]]
[[Category: Shikimis acid pathway]]
[[Category: Substrate specificity]]
[[Category: Type i dehydroquinase]]

Latest revision as of 15:12, 20 December 2023

Structure of Salmonella typhi type I dehydroquinase irreversibly inhibited with a 1,3,4-trihydroxyciclohexane-1-carboxylic acid derivativeStructure of Salmonella typhi type I dehydroquinase irreversibly inhibited with a 1,3,4-trihydroxyciclohexane-1-carboxylic acid derivative

Structural highlights

4clm is a 2 chain structure with sequence from Salmonella enterica subsp. enterica serovar Typhi. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
Method:X-ray diffraction, Resolution 1.4Å
Ligands:, ,
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Function

AROD_SALTI

Publication Abstract from PubMed

The irreversible inhibition of type I dehydroquinase (DHQ1), the third enzyme of the shikimic acid pathway, is investigated by structural, biochemical and computational studies. Two epoxides, which are mimetics of the natural substrate, were designed as irreversible inhibitors of the DHQ1 enzyme and to study the binding requirements of the linkage to the enzyme. The epoxide with the S configuration caused the covalent modification of the protein whereas no reaction was obtained with its epimer. The first crystal structure of DHQ1 from Salmonella typhi covalently modified by the S epoxide, which is reported at 1.4 A, revealed that the modified ligand is surprisingly covalently attached to the essential Lys170 by the formation of a stable Schiff base. The experimental and molecular dynamics simulation studies reported here highlight the huge importance of the conformation of the C3 carbon of the ligand for covalent linkage to this type of aldolase I enzyme, revealed the key role played by the essential His143 as a Lewis acid in this process and show the need for a neatly closed active site for catalysis.

Irreversible covalent modification of type I dehydroquinase with a stable Schiff base.,Tizon L, Maneiro M, Peon A, Otero JM, Lence E, Poza S, van Raaij MJ, Thompson P, Hawkins AR, Gonzalez-Bello C Org Biomol Chem. 2014 Nov 5. PMID:25370445[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

See Also

References

  1. Tizon L, Maneiro M, Peon A, Otero JM, Lence E, Poza S, van Raaij MJ, Thompson P, Hawkins AR, Gonzalez-Bello C. Irreversible covalent modification of type I dehydroquinase with a stable Schiff base. Org Biomol Chem. 2014 Nov 5. PMID:25370445 doi:http://dx.doi.org/10.1039/c4ob01782j

4clm, resolution 1.40Å

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA